Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Tango Therapeutics, Inc. (TNGX) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 6 Form 8-K material event filings were reported by TNGX in the last 90 days. 4 Form 144 notices of proposed sale were filed for TNGX stock. InsiderAlpha tracks every TNGX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001819133 |
|---|
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Crystal Adam | President, R&D | S — Open-market sale | 19.6K | $29.34 | $576K | SEC | |
| Crystal Adam | President, R&D | S — Open-market sale | 7.4K | $30.25 | $223K | SEC | |
| Crystal Adam | President, R&D | M — Option exercise | 27.0K | $5.20 | $140K | SEC | |
| Azelby Robert | Insider | A — Grant or award | 5.7K | $0.00 | — | SEC | |
| Ketchum John B | Insider | A — Grant or award | 4.0K | $0.00 | — | SEC | |
| Rothenberg Mace | Insider | A — Grant or award | 4.0K | $0.00 | — | SEC | |
| Calhoun Lesley Ann | Insider | A — Grant or award | 4.0K | $0.00 | — | SEC | |
| Lee Sung | Insider | A — Grant or award | 570 | $0.00 | — | SEC | |
| Crystal Adam | President, R&D | M — Option exercise | 27.0K | $5.20 | $140K | SEC | |
| Crystal Adam | President, R&D | S — Open-market sale | 20.9K | $23.06 | $481K | SEC | |
| Crystal Adam | President, R&D | S — Open-market sale | 6.1K | $22.25 | $137K | SEC | |
| Gall Matthew | Chief Financial Officer | A — Grant or award | 40.0K | $0.00 | — | SEC | |
| Crystal Adam | President, R&D | S — Open-market sale | 1.1K | $22.00 | $24K | SEC | |
| Crystal Adam | President, R&D | M — Option exercise | 27.0K | $5.20 | $140K | SEC | |
| Crystal Adam | President, R&D | S — Open-market sale | 25.9K | $21.19 | $549K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Tango Therapeutics, Inc. (TNGX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Crystal Adam | 12 | $2.41M |
| Lee Sung | 4 | — |
| Calhoun Lesley Ann | 2 | — |
| Rothenberg Mace | 2 | — |
| Ketchum John B | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TNGX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TNGX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.